Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Wang

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2008
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in ratsSonya G Lehto, Rami Tamir, Hong Deng, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin coreChristopher Fotsch, Gloria Biddlecome, Kaustav Biswas, et al.
NPJ Breast Cancer|August 16, 2025
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysisLetizia Pontolillo, Andrew A Davis, Lorenzo Gerratana, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammationJian Jeffrey Chen, Thomas Nguyen, Derin C D'Amico, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
ANZ Journal of Surgery|June 8, 2022
Frail patients having vascular surgery during the early COVID-19 pandemic experienced high rates of adverse perioperative events and amputation, Sarah J Aitken, Bernard Allard, et al.
Nature Genetics|October 30, 2019
HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotypeRajeev Malhotra, Andreas C Mauer, Christian L Lino Cardenas, et al.
American Journal of Human Genetics|February 11, 2014
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacksGina M Peloso, Paul L Auer, Joshua C Bis, et al.
Kidney International|November 2, 2020
Meta-analysis uncovers genome-wide significant variants for rapid kidney function declineMathias Gorski, Bettina Jung, Yong Li, et al.
Nature Communications|January 17, 2024
X-chromosome and kidney function: evidence from a multi-trait genetic analysis of 908,697 individuals reveals sex-specific and sex-differential findings in genes regulated by androgen response elementsMarkus Scholz, Katrin Horn, Janne Pott, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2008
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in ratsSonya G Lehto, Rami Tamir, Hong Deng, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin coreChristopher Fotsch, Gloria Biddlecome, Kaustav Biswas, et al.
NPJ Breast Cancer|August 16, 2025
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysisLetizia Pontolillo, Andrew A Davis, Lorenzo Gerratana, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammationJian Jeffrey Chen, Thomas Nguyen, Derin C D'Amico, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
ANZ Journal of Surgery|June 8, 2022
Frail patients having vascular surgery during the early COVID-19 pandemic experienced high rates of adverse perioperative events and amputation, Sarah J Aitken, Bernard Allard, et al.
Nature Genetics|October 30, 2019
HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotypeRajeev Malhotra, Andreas C Mauer, Christian L Lino Cardenas, et al.
American Journal of Human Genetics|February 11, 2014
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacksGina M Peloso, Paul L Auer, Joshua C Bis, et al.
Kidney International|November 2, 2020
Meta-analysis uncovers genome-wide significant variants for rapid kidney function declineMathias Gorski, Bettina Jung, Yong Li, et al.
Nature Communications|January 17, 2024
X-chromosome and kidney function: evidence from a multi-trait genetic analysis of 908,697 individuals reveals sex-specific and sex-differential findings in genes regulated by androgen response elementsMarkus Scholz, Katrin Horn, Janne Pott, et al.
Pageof 9